Report overview
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid ?over-treatment? of the cancer patients.
This report aims to provide a comprehensive presentation of the global market for Cancer Tumor Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tumor Profiling. This report contains market size and forecasts of Cancer Tumor Profiling in global, including the following market information:
Global Cancer Tumor Profiling Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Tumor Profiling market was valued at US$ 40550 million in 2022 and is projected to reach US$ 78790 million by 2030, at a CAGR of 10.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
We surveyed the Cancer Tumor Profiling companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Tumor Profiling Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Type, 2022 (%)
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Global Cancer Tumor Profiling Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Application, 2022 (%)
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Global Cancer Tumor Profiling Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Tumor Profiling Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Tumor Profiling revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Tumor Profiling revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Tumor Profiling, market overview.
Chapter 2: Global Cancer Tumor Profiling market size in revenue.
Chapter 3: Detailed analysis of Cancer Tumor Profiling company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Tumor Profiling in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
